Alexander Hovard Sparre-Ulrich

M.Sc., PhD, Co-founder, CEO

Award winning innovator that has led all commercialisation and development aspects since 2014.


Prof. Mette Marie Rosenkilde

MD, PhD, Co-founder, Acting CSO

Has a proven track record of translating innovative discoveries into spin-out companies.


Mikael Thomsen

M.Sc., PhD, Acting CDO

Extensive biotech experience in managing the activities necessary for taking a compound from late discovery to Phase II/cPoC.


Jakob Dynnes Hansen

M.Sc., MBA, Acting CFO

Has more than 25 years of combined experience from biotech and financing.


Ian Laquian

M.Sc., MBA, Acting CBO

EIR at Novo Seeds with extensive pharma & biotech experience.


Mette Høy Jensen

M.Sc., PhD student, Project lead – Orphan indications

Talented Industrial PhD student with previous biotech experience.

Go to Top